Economic Evaluation of NAB-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for The Management of Metastatic Pancreatic Cancer in Greece
Abstract
Authors
V. Fragoulakis P. Papakostas G. Pentheroudakis C. Dervenis N. Maniadakis